Journal
RADIATION RESEARCH
Volume 169, Issue 6, Pages 633-638Publisher
RADIATION RESEARCH SOC
DOI: 10.1667/RR1190.1
Keywords
-
Funding
- NCI NIH HHS [T32 CA009236, CA 09236, R01 CA043322-21, R01 CA043322, T32 CA009236-30, T32 CA009236-29, CA 43322] Funding Source: Medline
Ask authors/readers for more resources
Resveratrol, a polyphenol compound with reported antioxidant and anticarcinogenic effects, a wide range of molecular targets, and toxicity only at extreme doses, has received considerable attention. We evaluated the radioprotective effect of orally administered resveratrol on the frequencies of chromosome aberrations in irradiated mouse bone marrow cells. CBA/CaJ mice were divided into four groups: (1) no treatment, (2) resveratrol only, (3) radiation only, and (4) resveratrol and radiation. Resveratrol treatment (100 mg/kg daily) was initiated 2 days prior to irradiation. Bone marrow was then harvested at 1 and 30 days after a single dose of 3 Gy whole-body gamma radiation. A statistically significant (P < 0.05) reduction in the mean total chromosome aberration frequency per metaphase at both times postirradiation in the resveratrol and radiation group compared to the radiation-only group was observed. This study is the first to demonstrate that resveratrol has radioprotective effects in vivo. These results support the use of resveratrol as a radioprotector with the potential for widespread application. 0 2008 by Radiation Research Society.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available